![](/img/cover-not-exists.png)
A Markov Model Evaluating the Cost-Effectiveness of Ustekinumab Compared to Vedolizumab for patient's with Crohn’s Disease as Third-Line Therapy
Schneider, Yecheskel, Saumoy, Monica, Cohen-Mekelburg, Shirley A., Gold, Stephanie, Scherl, Ellen, Steinlauf, Adam F.Volume:
152
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(17)32115-7
Date:
April, 2017
File:
PDF, 600 KB
english, 2017